Doxycycline PEP is losing its grip on gonorrhoea — and the bacterium is winning the antibiotic-resistance race
Doxycycline taken after sex (doxyPEP) was supposed to cut gonorrhoea cases. A new Lancet study shows the protective effect collapsed within a year of rollout in California — as the tetM gene driving high-level tetracycline resistance spread rapidly through circulating gonorrhoea strains.
Read more →















